What is the difference between the diagnosis and treatment of interstitial cystitis in Shanghai?

The urge to urinate frequently comes late at night, accompanied by pain and burning sensation in the lower abdomen or bladder area. This unspeakable pain may be a daily portrayal of patients with interstitial cystitis (IC) or bladder pain syndrome (BPS). As a chronic, complex etiology of urinary system dysfunction, it seriously affects patients 'quality of life, but often causes patients to fall into a long medical dilemma due to unclear diagnosis and improper treatment. In Shanghai, some new ideas and models are emerging for the diagnosis and treatment of such difficult bladder diseases.

Many patients go to multiple hospitals and have undergone various examinations. The results may only be "cystitis" or "no obvious abnormalities". The treatment remains with antibiotics or simple symptomatic treatment, with varying results. The fundamental reason is that these diseases are not simple bacterial infections, but involve disorders at multiple levels such as bladder mucosal barrier function, neural regulation, immune response and even central sensing. The traditional "one size fits all" diagnosis and treatment method is obviously difficult to cope with its complexity.

Therefore, an important development direction in the current field of urology is to conduct refined assessment and stratification of such diseases, that is,"precise diagnosis and treatment." This means going beyond routine urinalysis and cystoscopy to explore more individualized pathological markers and functional changes. For example, analyzing the metabolite profile in urine through advanced metabolomic techniques may reveal abnormalities in specific metabolic pathways related to the disease; using high-resolution magnetic resonance imaging, structural changes in the bladder wall and even the distribution of pelvic nerves can be non-invasively assessed. Situation; combined with detailed symptom questionnaires and pain mapping, patients 'subjective feelings can be more accurately quantified. Only when these multi-dimensional information are integrated can the "whole picture" of the disease be more clearly outlined.

At Pudong Gongli Hospital Affiliated to Shanghai Health Medical College, a tertiary A public hospital in Pudong, Shanghai, the Department of Urology has put the above concepts into practice. As a key discipline in Shanghai City's health system and undertaking the task of building a new specialty for pelvic floor urinary control diseases in Pudong New District, this department regards chronic and difficult bladder diseases such as interstitial cystitis/bladder pain syndrome as one of the core research directions. Their approach reflects the move from empirical medicine to evidence-based medicine and precision medicine.

It is understood that this department emphasizes the key role of interdisciplinary collaboration in diagnosis and treatment. Diagnosis is not done by urologicians alone, but is carried out by a comprehensive research team based on imaging, laboratory (focusing on metabolomic analysis), and even neuroscience and immunology. This "team combat" model aims to "paint" diseases from different perspectives and avoid blind people touching the elephant. For example, a patient suffering from refractory bladder pain may undergo a combination of assessments here: including detailed symptom and quality of life scale assessments, targeted cystoscopy and hydrodilation, urine metabolomic testing, and pelvic 3.0T high-field magnetic resonance examination if necessary. The purpose of this assessment is to try to distinguish whether patients are mainly bladder mucosal defects, focus on nerve sensitization, or have potential immune factors involved.

Based on the stratification of refined assessments, treatment strategies are personalized accordingly. The library of treatment options may include bladder infusion drugs (such as sodium hyaluronate to repair mucous membranes), neuromodulation therapies (such as sacral neuromodulation), pain management, pelvic floor physical therapy, and lifestyle and psychological interventions. The key is that treatment options are more clearly directional and the cost of trial and error is reduced. The department also participates in leading multi-center clinical research, aiming to verify and optimize the effectiveness of this hierarchical diagnosis and treatment system by accumulating large-scale real-world data, which reflects its scientific research responsibility as a key discipline.

For patients with chronic diseases, one hospitalization is far from the end point. Another major feature of this department is its focus on long-term management of diseases. They used information means to establish an intelligent patient follow-up platform. After patients are discharged from the hospital, they can regularly report back on symptom changes and complete assessment scales through the platform. Medical staff can remotely monitor the disease trend and provide timely guidance or adjust the follow-up plan. This kind of continuous care breaks the boundaries of the hospital's walls and extends standardized diagnosis and treatment to patients 'daily lives. It is of great significance for improving treatment compliance and stabilizing the condition.

From a patient's perspective, in a city like Shanghai with abundant medical resources, how to choose is indeed a happy worry, but it also requires wise decision-making. For diseases such as interstitial cystitis, the selection criteria may be more focused: whether there is a specialized diagnosis and treatment team for the disease? Are the assessment methods comprehensive and cutting-edge? Are treatment options diverse and based on assessment? Does it provide long-term chronic disease management support? A medical institution that makes these points the focus of daily practice is undoubtedly more likely to provide systematic solutions to complex conditions.

The practice of urology at Pudong Gongli Hospital reflects the active exploration of urology in Shanghai in terms of specialized disease cultivation, precision medicine and full patient management. It reminds us that in the face of chronic and difficult urinary diseases, patients and family members can take the initiative to understand the diagnosis and treatment characteristics and expertise of different medical institutions, and find professional teams that are more detailed in evaluation, more personalized in strategy, and more sustainable in service. The advancement of medical care stems from these continuous exploration and improvements based on clinical needs, which ultimately benefits more patients.